State Street’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18M | Buy |
5,202,791
+43,599
| +0.8% | +$151K | ﹤0.01% | 2245 |
|
|
2025
Q1 | $13.5M | Sell |
5,159,192
-120,534
| -2% | -$316K | ﹤0.01% | 2341 |
|
|
2024
Q4 | $21.8M | Buy |
5,279,726
+979,510
| +23% | +$4.04M | ﹤0.01% | 2185 |
|
|
2024
Q3 | $30.4M | Buy |
4,300,216
+51,810
| +1% | +$367K | ﹤0.01% | 1965 |
|
|
2024
Q2 | $27.7M | Sell |
4,248,406
-1,772,582
| -29% | -$11.6M | ﹤0.01% | 1993 |
|
|
2024
Q1 | $50M | Buy |
6,020,988
+1,117,410
| +23% | +$9.27M | ﹤0.01% | 1731 |
|
|
2023
Q4 | $54M | Sell |
4,903,578
-3,011
| -0.1% | -$33.2K | ﹤0.01% | 1663 |
|
|
2023
Q3 | $41.3M | Sell |
4,906,589
-2,304,208
| -32% | -$19.4M | ﹤0.01% | 1736 |
|
|
2023
Q2 | $90.6M | Buy |
7,210,797
+1,330,516
| +23% | +$16.7M | ﹤0.01% | 1287 |
|
|
2023
Q1 | $96.8M | Sell |
5,880,281
-384,216
| -6% | -$6.33M | 0.01% | 1208 |
|
|
2022
Q4 | $93.6M | Buy |
6,264,497
+2,596,427
| +71% | +$38.8M | 0.01% | 1195 |
|
|
2022
Q3 | $82.1M | Sell |
3,668,070
-1,110,349
| -23% | -$24.8M | 0.01% | 1246 |
|
|
2022
Q2 | $80M | Buy |
4,778,419
+1,524,727
| +47% | +$25.5M | ﹤0.01% | 1324 |
|
|
2022
Q1 | $97.4M | Buy |
3,253,692
+67,170
| +2% | +$2.01M | ﹤0.01% | 1317 |
|
|
2021
Q4 | $97.9M | Buy |
3,186,522
+504,846
| +19% | +$15.5M | ﹤0.01% | 1313 |
|
|
2021
Q3 | $84.6M | Buy |
2,681,676
+463,516
| +21% | +$14.6M | ﹤0.01% | 1410 |
|
|
2021
Q2 | $81.2M | Buy |
2,218,160
+202,584
| +10% | +$7.41M | ﹤0.01% | 1467 |
|
|
2021
Q1 | $69.7M | Buy |
2,015,576
+688,871
| +52% | +$23.8M | ﹤0.01% | 1499 |
|
|
2020
Q4 | $55.1M | Buy |
1,326,705
+848,817
| +178% | +$35.3M | ﹤0.01% | 1575 |
|
|
2020
Q3 | $20.4M | Buy |
+477,888
| New | +$20.4M | ﹤0.01% | 2030 |
|